News

Sinovac’s net income was $1.88m, compared to $1.56m for the same period in the prior year. The company’s operating income was $3.13m for the second quarter ended 30

Following the signing of the expended deal, SOBI has placed an additional order for vials of Ruconest from Pharming. The shipment forms part of SOBI’s preparation for the

The licensing deal allows Roche to get milestone payments from Chugai Pharma. Chugai Pharma intends to begin a Phase I clinical trial for BRAF mutation-positive metastatic melanoma in

Prior to Addex, Chowrira worked as the senior vice president & chief operating officer of Nektar Therapeutics till January 2011. Before Nektar, Chowrira worked as the executive director

Simvastatin is used together with diet and exercise to reduce the amount of ‘bad cholesterol’ (low-density lipoprotein cholesterol or LDL-C) in the blood. The US Food and Drug

Colcrys is a single-ingredient colchicine product, indicated for the prophylaxis and treatment of gout flares, and for the treatment of Familial Mediterranean Fever (FMF). The studies are intended

Currently, the company has started designing a Phase III trial program and protocol to evaluate AmiKet in patients with chemotherapy-induced neuropathic pain (CIPN) to submit the new drug

Nordion provides targeted therapies and sterilization technologies to pharma and biotechnology companies, hospitals, clinics and research laboratories. Nordion will initially implement Pilgrim’s automated Document Management and Change Management

The company’s operating loss for the second quarter of 2011 was $2.99m, compared to $1.35m for the same period in 2010. For the six months ended 30 June